On April 6, Ohio Governor Mike DeWine signed Executive Order 2022-05D to suspend the normal rulemaking process to allow the State of Ohio Board of Pharmacy to classify a number of bezimidazole-opioids as Schedule One drugs, meaning they have no accepted medical use in treatment and pose an imminent hazard to public health, safety, and welfare.
In This Issue
Previous Issues
Comments
Leave a Comment
Your email address will not be published.